Australia, April 9 -- CELLTRION Inc., owns the trademark (2615230) for 'IMSECMA' till Nov. 21, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of inflammatory diseases; monoclonal antibodies for medical purposes; medicines for human purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of hidradenitis suppurativa.]
Type of Mark: Word
Date of Acceptance: Jan. 28
Registration Advertised: April 8
For further details contact JIDAM IP LAW FIRM.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2615230.
Disclaimer: Curated by HT Syndication.
